OraSure Hep C Testing Grant (Deadline 9/1/16)
The OraSure HCV Grant Program is a recently announced funding opportunity designed to foster innovative approaches to HCV testing. The program is seeking proposals that demonstrate the effective use of rapid HCV screening in identifying positive individuals in a specific public healthcare setting and linking those individuals into care. Award recipients will receive (up to) 300 OraQuick® HCV Rapid Antibody Test Kits and (up to) $5,000 in funding to support data collection and analysis. Please visit the project website for more information, including the program rules and eligibility requirements, and to apply. Applications must be completed and submitted by September 1, 2016.
All of the following applicants are encouraged to apply:
- Public health entities that have not yet deployed rapid HCV testing
- Public health professionals who are looking at implementing the use of rapid HCV testing in non-traditional settings
- Community-based organizations considering the use of rapid HCV testing in their clinics or outreach events